IL17A and metabolic dysfunction-associated steatotic liver disease: Additionally, the release of cytokines, including IL-17, can contribute to non-alcoholic fatty liver disease, leading to decreased ATP production in the liver and consequently an increase in uric acid production (Huang et al., 2020).